Raya Therapeutic Announces Selection of RT1999 (Smilagenin) onto the EXPERTS-ALS Clinical Trial Platform
Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster at the MDA Conference MONTREAL, QUEBEC, CANADA, March 9, 2026 /EINPresswire.com/ -- Raya Therapeutic Inc. (“Raya”), a mission …